Monday, July 29, 2013 5:43:16 PM
Published on: 29th Jul 2013
The two majority shareholders in Israeli telecoms operator, Golan Telecom are reported to have received an approach to buy the rival mobile network, Cellcom Israel.
Citing sources familiar with the matter, Globes reported that Cellcom's controlling shareholder, the financially troubled IDB Holding has put its stake up for sale.
The company has denied this, but Globes says that it has other sources confirming that a sale is being discussed.
All the Israeli networks have suffered from increased competition and a hostile regulatory regime in recent years, and consolidation has been expected between a couple of the networks.
Cellcom is the country's largest mobile network, while Golan Telecom is a low-cost new entrant to the market that secured its license in 2011.
http://www.cellular-news.com/story/61239.php
Recent CEL News
- Celadon hails early results of chronic pain trial • Alliance News • 03/08/2024 08:04:45 PM
- Celadon Pharmaceuticals PLC Early Economic Analysis of Feasibility Study Data • RNS Non-Regulatory • 03/07/2024 07:00:13 AM
- Celadon announces start of cannabis supply for two UK companies • Alliance News • 12/14/2023 02:18:53 PM
- Celadon Pharmaceuticals PLC Product Supplied to First Two Sales Contracts • UK Regulatory • 12/14/2023 07:00:00 AM
- Celadon Pharma raises GBP2.0 million via placing • Alliance News • 12/12/2023 05:40:04 PM
- Celadon Pharmaceuticals PLC Fundraise, Update on Future CLN Financing & TVR • UK Regulatory • 12/12/2023 02:00:00 PM
- Celadon shares rise on supply contract worth up to GBP26 million • Alliance News • 11/16/2023 11:45:35 AM
- Celadon Pharmaceuticals PLC New European Sales Contract • UK Regulatory • 11/16/2023 07:00:00 AM
- Celadon Pharmaceuticals raises GBP1.0 million through shares • Alliance News • 10/13/2023 02:42:26 PM
- Celadon Pharmaceuticals PLC Fundraise, CLN Issue, Joint Broker Appointed & TVR • UK Regulatory • 10/13/2023 06:00:00 AM
- Celadon Pharmaceuticals interim loss narrows; optimistic for future • Alliance News • 09/28/2023 11:14:47 AM
- Celadon Pharmaceuticals PLC Interim Results • UK Regulatory • 09/28/2023 06:00:00 AM
- Celadon Pharmaceuticals PLC Notice of Results and Investor Presentation • UK Regulatory • 09/18/2023 06:00:00 AM
- Celadon shares rise on second UK contract win for cannabis product • Alliance News • 09/05/2023 09:48:42 AM
- Celadon Pharmaceuticals PLC New Sales Contract with UK Pharmaceutical Company • UK Regulatory • 09/05/2023 06:00:00 AM
- Celadon receives approval for 5,000 patient clinical cannabis trial • Alliance News • 08/01/2023 10:44:46 AM
- Celadon Pharmaceuticals PLC Approval to roll-out chronic pain clinical trial • UK Regulatory • 08/01/2023 06:00:00 AM
- Celadon Pharmaceuticals PLC Result of AGM • UK Regulatory • 06/29/2023 04:30:00 PM
- Celadon Pharmaceuticals PLC Publication of Annual Report and Notice of AGM • UK Regulatory • 06/05/2023 01:46:00 PM
- Celadon Pharmaceuticals loss widens; confident amid three-year deal • Alliance News • 06/05/2023 11:23:05 AM
- Celadon Pharmaceuticals PLC Final Results for the year ended 31 December 2022 • UK Regulatory • 06/05/2023 06:00:00 AM
- Celadon secures GBP7 million credit facility as product demand grows • Alliance News • 05/30/2023 10:56:00 AM
- Celadon Pharmaceuticals PLC GBP7 Million Committed Credit Facility • UK Regulatory • 05/30/2023 06:00:00 AM
- Celadon Pharmaceuticals PLC Notice of Results and Investor Presentation • UK Regulatory • 05/26/2023 06:00:00 AM
- Celadon Pharmaceuticals PLC West Midlands Mayor Visits Celadon's Facility • RNS Non-Regulatory • 05/25/2023 06:00:00 AM
FEATURED Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • BLOZF • May 7, 2024 8:51 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM